Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE

Overview of attention for article published in Journal of Nuclear Medicine, March 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter: 11 X users

guideline: 2 clinical guideline sources

Readers on

mendeley: 21 Mendeley

So far, Altmetric has seen 13 X posts from 11 X users, with an upper bound of 26,257 followers.

RT @CarcinoidNETs: Reduction in abdominal pain, diarrhea and flushing -- improvements in quality of life for #NeuroendocrineTumor patients…

Reduction in abdominal pain, diarrhea and flushing -- improvements in quality of life for #NeuroendocrineTumor patients treated with #PRRT.

RT @JournalofNucMed: Symptom diaries of patients with midgut #NeuroendocrineTumors treated with Lu-177 DOTATATE reflect clinically and stat…

RT @samira_sadowski: So important for patients undergoing Lu177-DOTATATE with reduction in their symptoms #NET @NANETS1

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 9 additional X posts.